Literature DB >> 18557740

Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.

N Kamar1, J-M Mansuy, O Cointault, J Selves, F Abravanel, M Danjoux, P Otal, L Esposito, D Durand, J Izopet, L Rostaing.   

Abstract

Hepatitis E virus (HEV) infection was thought to be responsible for acute hepatitis that did not become chronic. However, we have recently reported that HEV infection can evolve to chronic hepatitis, at least in solid-organ transplant patients. We report on two cases of rapidly progressive of HEV-related cirrhosis that occurred in two organ-transplant patients. Case 1: A kidney-pancreas-transplant patient developed acute HEV hepatitis 60 months after transplantation, which evolved to chronicity as defined by persisting elevated liver-enzyme levels and positive serum HEV RNA. At 22 months after the acute phase, she presented with cirrhosis and portal hypertension, that is ascites and esophagus varices. Case 2: A kidney-transplant patient developed acute hepatitis 36 months after transplantation, which persisted and remained unexplained for 38 months. Then, HEV RNA was searched for in their serum and stools, and was found to be positive in both. Retrospective analysis of available stored serum, mainly the serum obtained at the acute phase, confirmed the diagnosis of chronic hepatitis E. In both cases, a liver biopsy showed cirrhosis. We conclude that HEV infection cannot only evolve to chronic hepatitis, but can also be responsible for rapidly progressing cirrhosis in organ-transplant patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557740     DOI: 10.1111/j.1600-6143.2008.02286.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  52 in total

1.  Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic.

Authors:  Alice I Goumba; Xavier Konamna; Narcisse P Komas
Journal:  BMC Infect Dis       Date:  2011-04-14       Impact factor: 3.090

Review 2.  Development of new hepatitis E vaccines.

Authors:  Yufeng Cao; Zhenhong Bing; Shiyu Guan; Zecai Zhang; Xinping Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

Review 3.  Clinical features and determinants of chronicity in hepatitis E virus infection.

Authors:  Shivakumar Narayanan; Ameer Abutaleb; Kenneth E Sherman; Shyam Kottilil
Journal:  J Viral Hepat       Date:  2019-02-05       Impact factor: 3.728

Review 4.  Chronic hepatitis e virus infection and treatment.

Authors:  Nassim Kamar; Jacques Izopet; Harry R Dalton
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

5.  [Prevention of virus hepatitis A to E].

Authors:  M Cornberg; M P Manns
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

6.  The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release.

Authors:  Scott P Kenney; R S Pudupakam; Yao-Wei Huang; F William Pierson; Tanya LeRoith; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

Review 7.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

8.  Serological evidence for a hepatitis e virus-related agent in goats in the United States.

Authors:  B J Sanford; S U Emerson; R H Purcell; R E Engle; B A Dryman; T E Cecere; V Buechner-Maxwell; D P Sponenberg; X J Meng
Journal:  Transbound Emerg Dis       Date:  2012-08-22       Impact factor: 5.005

Review 9.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

10.  [Diagnostics and therapy of hepatitis].

Authors:  C P Strassburg; M Cornberg
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.